Claude Hattab

598 total citations
28 papers, 461 citations indexed

About

Claude Hattab is a scholar working on Physiology, Molecular Biology and Hematology. According to data from OpenAlex, Claude Hattab has authored 28 papers receiving a total of 461 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Physiology, 13 papers in Molecular Biology and 10 papers in Hematology. Recurrent topics in Claude Hattab's work include Erythrocyte Function and Pathophysiology (14 papers), Blood groups and transfusion (8 papers) and Glycosylation and Glycoproteins Research (4 papers). Claude Hattab is often cited by papers focused on Erythrocyte Function and Pathophysiology (14 papers), Blood groups and transfusion (8 papers) and Glycosylation and Glycoproteins Research (4 papers). Claude Hattab collaborates with scholars based in France, Argentina and United States. Claude Hattab's co-authors include Olivier Bertrand, Caroline Le Van Kim, Jean‐Pierre Cartron, Mariano A. Ostuni, Cécile Rahuel, Sophie D. Lefevre, Christophe Tournamille, JP Cartron, G. A. Boffa and Stany Chrétien and has published in prestigious journals such as Blood, PLoS ONE and Analytical Biochemistry.

In The Last Decade

Claude Hattab

28 papers receiving 456 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Claude Hattab France 15 207 192 178 68 59 28 461
Martine Huet France 9 241 1.2× 183 1.0× 246 1.4× 77 1.1× 65 1.1× 14 512
J. Aura Gimm United States 8 292 1.4× 220 1.1× 92 0.5× 60 0.9× 60 1.0× 8 533
G. Salvo Italy 7 73 0.4× 188 1.0× 84 0.5× 112 1.6× 54 0.9× 10 374
Tosti J. Mankelow United Kingdom 13 399 1.9× 177 0.9× 197 1.1× 177 2.6× 116 2.0× 22 617
Anoop K. Sendamarai United States 10 91 0.4× 315 1.6× 214 1.2× 203 3.0× 26 0.4× 14 649
Mika Kikkawa Japan 13 184 0.9× 284 1.5× 47 0.3× 18 0.3× 38 0.6× 22 620
Brian I. Lord United Kingdom 18 67 0.3× 149 0.8× 222 1.2× 87 1.3× 136 2.3× 34 655
Seana C. Catherman United States 7 121 0.6× 232 1.2× 116 0.7× 67 1.0× 184 3.1× 12 500
Raymond B. Hester United States 13 101 0.5× 126 0.7× 48 0.3× 60 0.9× 109 1.8× 26 472
Amy E. Campbell United States 17 96 0.5× 944 4.9× 178 1.0× 128 1.9× 74 1.3× 28 1.1k

Countries citing papers authored by Claude Hattab

Since Specialization
Citations

This map shows the geographic impact of Claude Hattab's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Claude Hattab with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Claude Hattab more than expected).

Fields of papers citing papers by Claude Hattab

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Claude Hattab. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Claude Hattab. The network helps show where Claude Hattab may publish in the future.

Co-authorship network of co-authors of Claude Hattab

This figure shows the co-authorship network connecting the top 25 collaborators of Claude Hattab. A scholar is included among the top collaborators of Claude Hattab based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Claude Hattab. Claude Hattab is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Schachter, Julieta, María Paula Faillace, Gerardo R. Corradi, et al.. (2021). Extracellular ATP hydrolysis in Caco-2 human intestinal cell line. Biochimica et Biophysica Acta (BBA) - Biomembranes. 1863(10). 183679–183679. 4 indexed citations
2.
Moras, Martina, Claude Hattab, Pedro González‐Menéndez, et al.. (2021). Human erythroid differentiation requires VDAC1-mediated mitochondrial clearance. Haematologica. 107(1). 167–177. 19 indexed citations
3.
Ostuni, Mariano A., Patricia Hermand, Noëlline Guillou, et al.. (2020). CX3CL1 homo-oligomerization drives cell-to-cell adherence. Scientific Reports. 10(1). 9069–9069. 16 indexed citations
5.
Alvarez, Cora Lilia, Martina Moras, María Florencia Leal Denis, et al.. (2018). Human erythrocytes release ATP by a novel pathway involving VDAC oligomerization independent of pannexin-1. Scientific Reports. 8(1). 11384–11384. 28 indexed citations
6.
Hattab, Claude, et al.. (2017). Recombinant Overexpression of Mammalian TSPO Isoforms 1 and 2. Methods in molecular biology. 1635. 1–25. 4 indexed citations
7.
Hattab, Claude, Guillaume Bouyer, François Hallé, et al.. (2016). TSPO ligands stimulate ZnPPIX transport and ROS accumulation leading to the inhibition of P. falciparum growth in human blood. Scientific Reports. 6(1). 33516–33516. 18 indexed citations
8.
Hattab, Claude, Radosław Kaczmarek, Anna Jarząb, et al.. (2015). Studies of a Murine Monoclonal Antibody Directed against DARC: Reappraisal of Its Specificity. PLoS ONE. 10(2). e0116472–e0116472. 5 indexed citations
9.
González, Débora A., et al.. (2014). Rat submandibular glands secrete nanovesicles with NTPDase and 5′-nucleotidase activities. Purinergic Signalling. 11(1). 107–116. 6 indexed citations
10.
Habib, Ibrahim, Claude Hattab, Gholamreza Hassanzadeh‐Ghassabeh, et al.. (2013). VHH (nanobody) directed against human glycophorin A: A tool for autologous red cell agglutination assays. Analytical Biochemistry. 438(1). 82–89. 30 indexed citations
11.
Hattab, Claude, Gholamreza Hassanzadeh‐Ghassabeh, Sylvie Cochet, et al.. (2010). A recombinant dromedary antibody fragment (VHH or nanobody) directed against human Duffy antigen receptor for chemokines. Cellular and Molecular Life Sciences. 67(19). 3371–3387. 38 indexed citations
12.
Clapéron, Audrey, Claude Hattab, Vincent Armand, et al.. (2007). The Kell and XK proteins of the Kell blood group are not co-expressed in the central nervous system. Brain Research. 1147. 12–24. 20 indexed citations
13.
Hattab, Claude, Dominique Blanchard, Pierre Gane, et al.. (2003). A new murine monoclonal antibody against Kx protein. Transfusion Medicine. 13(1). 43–48. 1 indexed citations
14.
Camara‐Clayette, Valérie, Cécile Rahuel, Claude Lopez, et al.. (2001). Transcriptional regulation of the KEL gene and Kell protein expression in erythroid and non-erythroid cells. Biochemical Journal. 356(1). 171–171. 22 indexed citations
15.
Colin, Yves, et al.. (1999). Structure and expression of the mouse homologue of the XK gene. Immunogenetics. 50(1-2). 16–21. 10 indexed citations
16.
Cochet, Sylvie, Antoine Blancher, F. Roubinet, et al.. (1999). Immunopurification of the blood group RhD protein from human erythrocyte membranes. Journal of Chromatography B Biomedical Sciences and Applications. 735(2). 207–217. 4 indexed citations
17.
Hattab, Claude, et al.. (1998). Kx, a Quantitatively Minor Protein from Human Erythrocytes, Is Palmitoylatedin Vivo. Biochemical and Biophysical Research Communications. 250(3). 569–574. 3 indexed citations
18.
Hattab, Claude, et al.. (1997). Immunochemical analysis of the Kx protein from human red cells of different Kell phenotypes using antibodies raised against synthetic peptides. British Journal of Haematology. 96(4). 857–863. 36 indexed citations
19.
Tournamille, Christophe, et al.. (1991). Cloning of the gene encoding the human erythropoietin receptor. Blood. 78(10). 2557–2563. 8 indexed citations
20.
Vignal, Alain, Cécile Rahuel, Jacqueline London, et al.. (1990). A novel gene member of the human glycophorin A and B gene family. European Journal of Biochemistry. 191(3). 619–625. 47 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026